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Abstract
Background: Research has demonstrated consistent associations between anxiety and illicit drug 
use. However, few studies to date have examined the shared risk factors that may contribute to this 
common comorbidity. Therefore, the current investigation tested the indirect effect of trait anxiety 
on drug use disorder symptoms via emotion dysregulation, a widely recognized transdiagnostic 
risk factor found to be relevant across both anxiety and illicit drug use.
Method: The sample was comprised of 241 adults (Mage = 50.56, SDage = 5.90; 76.8% Black) 
recruited from a community center serving low-income and homeless individuals. Results: 
Consistent with our hypothesis, structural equation modeling demonstrated an indirect effect of 
trait anxiety on drug use disorder symptoms through emotion dysregulation.
Conclusions: The current findings show initial support for emotion dysregulation as an 
explanatory vulnerability factor indirectly underlying the relationship between anxiety and drug 
use.
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The experience of anxiety is universal, yet, at greater levels, it may become a significant 
source of individual suffering (Whiteford et al., 2013). Approximately one in three adults in 
the U.S. develop an anxiety disorder at some point in their lives (Bandelow & Michaelis, 
2015). Consistent with national and international patterns of psychopathology (Andrade, 
Caraveo-Anduaga & Berglund, 2000), anxiety disorders tend to be overrepresented among 
individuals with low socioeconomic status (e.g., Johnson, Cohen, Dohrenwend, Link, & 
Brook, 1999; Brown, Harris & Eales, 1993); extant research has documented that having an 
income at or below the poverty level increases the odds of meeting criteria for anxiety (AOR 
= 1.44; 95% CI = 0.70-4.31), possibly as a result of the ongoing stress, uncertainty, and 
demoralization experienced by these individuals (e.g., Miech, Caspi, Moffitt, Entner, Silva 
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1999; Santiago, Wadsworth, Stump, 2011). In fact, poverty-related stress shows direct 
associations to anxiety symptoms, which tend to worsen across time (Santiago et al., 2011),
Anxiety tends to co-occur with other psychiatric disorders, leading to worse psychosocial 
outcomes and greater impairment relative to those individuals with an exclusive diagnosis of 
anxiety (Smith & Book, 2010). A particularly detrimental, and common comorbidity exists 
between anxiety and drug use disorders (Lai, Cleary. Sitharthan, Hunt, 2015); 18 to 20% of 
individuals with one diagnosis also meet criteria for the other disorder (Grant et al., 2004). 
Furthermore, having an income at or below the poverty level significantly increases the 
likelihood of meeting criteria for a substance use disorder (AOR = 1.53; 95% CI = 
0.48-4.85) (Johnson et al., 1999). The anxiety - drug use connection constitutes a significant 
public health challenge and a societal economic burden, requiring more than $240 billion in 
annual costs related to healthcare, lost productivity, and crime (Dupont et al., 1996; 
Whiteford et al., 2013). Although there is strong evidence surrounding the high rates of co-
occurring anxiety and drug use, explanatory psychological vulnerabilities that govern this 
relationship warrant more research. Greater knowledge on the pathways by which trait 
anxiety is linked to drug use would help identify important targets of intervention (Baillie et 
al., 2010), which constitutes an important research endeavor among low-income individuals 
who tend to have a greater rates of co-occurring drug use and anxiety and have been 
historically underserved in clinical research (e.g., Rad, Martingano & Ginges, 2018).
One factor that may be central in the connection between anxiety and drug use is emotion 
dysregulation. Broadly, emotion dysregulation refers to individuals’ tendency to experience 
emotions intensely and uncontrollably to the point of obscuring their capacity to cope with 
and regulate said emotions (Linehan & Heard, 1992; Gross, 2002; Shedler & Westen, 2004). 
The developmental psychopathology literature has noted that early childhood adversity, 
including growing up in poverty, has a positive association with emotion dysregulation (e.g., 
Calkins & Hill, 2007). Moreover, individuals with anxiety oftentimes struggle with 
recognizing their emotional experience, have negative reactions to their emotions, and have a 
diminished capacity to recover following the experience of negative emotionality in 
comparison to individuals without anxiety (Mennin, Heimberg, Turk & Fresco, 2005; Sloan 
et al., 2017). Heightened emotional intensity has shown strong positive correlations with 
using substances to alleviate distress (Berking, et al., 2011; Bonn-Miller, Vujanonic & 
Zvolensky, 2008). In fact, prominent paradigms of substance use suggest that individuals are 
motivated to use substances to escape from or avoid aversive negative emotionality and its 
corresponding uncomfortable physiological symptoms (e.g., Baker et al., 2004; Solomon & 
Corbit, 1974). Supporting these theories, emotion dysregulation, and specifically one’s 
inability to tolerate negative emotions, predicted relapse during and after psychotherapy for 
alcohol use dependence (Berking et al., 2011). While several investigations have identified 
the key role of emotion dysregulation on both anxiety and drug use problems independently, 
to our knowledge, no study to date has considered emotion dysregulation as an underlying 
link between these constructs with one exception, which focused on alcohol use. A recent 
study among Latinx adults in a primary care setting found evidence of a statistically 
significant indirect effect of anxiety on problematic alcohol use through emotion 
dysregulation (Paulus et al., 2017). To add to this emerging, yet scarce literature focused on 
explaining the relation between anxiety and drug use, the current study focused on a low-
Collado et al. Page 2













income non-treatment seeking sample. The present investigation examined the indirect effect 
of trait anxiety on drug use disorder symptoms via emotion dysregulation using structural 
equation modeling. We hypothesized that trait anxiety would be related to drug use disorder 
symptoms through its association with emotion dysregulation above and beyond 
theoretically-relevant covariates demonstrated to impact drug use disorders including age, 
ethnicity/race, and gender (Kilpatrick et al, 2000).
Method
All procedures were approved by the [University of Maryland-College Park’s] Institutional 
Review Board. Participants were recruited via flyers designed to target adults from a 
community center in Baltimore, Maryland that serves low-income and homeless adults who 
were interested in completing a computerized program to improve working memory. The 
center provides a number of services for the neighborhood, including free hot lunches and 
basic health services. The study consists of a secondary analysis of data from individuals 
who completed a battery of questionnaires to determine whether they were eligible to 
participate in a study that evaluated a cognitive training program to improve working 
memory. The present study includes all available data from individuals who completed the 
eligibility process, regardless of whether they qualified or not for the study. The battery of 
questionnaires included demographic information items, information about drug use, 
emotion dysregulation, and trait anxiety. Participants received $5.00 for completing the 
battery of questionnaires.
Materials and Measures
Demographic Characteristics.—Participants completed a demographics questionnaire 
that was developed to assess participants’ age, gender, race/ethnicity, education, and 
household income. Gender was coded as (0) male and (1) female and race/ethnicity was 
dichotomized and coded as (0) non-black/African-American and (1) black/African-
American. The race/ethnicity variable was dichotomized due to small cell sizes for 
individuals from other races/ethnicities.
Emotion dysregulation.—The Difficulties in Emotion Regulation Scale (DERS; Gratz 
and Roemer, 2004), is a 36-item instrument that assesses six facets of emotion regulation, 
including non-acceptance of emotional responses, difficulties engaging in goal directed 
behavior, impulse control difficulties, lack of emotional awareness, access to emotion 
regulation strategies, and lack of emotional clarity. Respondents were asked to rate a series 
of statements on a scale from 1 (almost never) to 5 (almost always). Scores are calculated by 
summing responses in each of the subscales and scores range between 0 and 180, with 
higher scores representing a greater degree of emotion dysregulation. The DERS has been 
used widely across various populations and demonstrates good internal consistency (Gratz 
and Roemer, 2004; Weinberg and Klonsky, 2009). In the current study, internal consistency 
for the DERS was excellent at α = 0.95.
Anxiety.—To measure trait anxiety, participants completed the State-Trait Anxiety 
Inventory for Trait Anxiety (STAI; Spielberger, 2010) in which respondents rate how they 
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“generally feel” on a series of 20 items using a 4-point Likert scale. Response options range 
from “almost never” to “almost always.” Scores are computed by adding the response 
values. Individuals are presented with statements such as “I am a steady person” or “I lack 
self-confidence.” The STAI for Trait Anxiety has demonstrated good internal consistency, 
test–retest reliability, and convergent and discriminant validity in clinical and non-clinical 
samples (Barnes et al., 2002; Hishinuma et al., 2000; Kabacoff, Segal, Hersen, & Van 
Hasselt, 1997; Vautier, 2004). In the present study, the Inventory demonstrated excellent 
internal consistency (α = 0.93).
Drug Use.—The Drug History Questionnaire (Sobell, Kwan, & Sobell, 1995) was used to 
assess the types and frequency of drug use in the last six months. Types of drugs assessed 
via the Questionnaire include alcohol, cannabis, hallucinogens, depressants, inhalants, 
narcotics, stimulants, tranquilizers, caffeine, nicotine, and other drugs. Additionally, 
participants completed the 11-item Drug Use Disorders Identification Test (DUDIT), 
intended to identify individuals with drug use problems, with higher scores on the measure 
representing greater drug use disorder symptoms. Participants answer questions such as 
“how many times do you take drugs on a typical day when you use drugs?” and “Over the 
past year, have you felt that your longing for drugs was so strong that you could not resist 
it?” Total scores are calculated by summing the points for each item. Clinical cut-off scores 
for men have been suggested at 6 or more, and for women at 2 or more. The DUDIT has 
strong psychometric properties with clinical and non-clinical populations, including high 
convergent validity, discriminant validity, and internal consistency (alpha = 0.94), with high 
sensitivity and specificity scores (Berman, Bergman, Palmstieran & Schlyter, 2005; Voluse 
et al., 2012). In the current study, the internal consistency of the instrument was α = .93.
Participants
All available data were used. Of the 241 individuals who completed the screening 
questionnaire, 4 were missing data on all predictor variables while 14 were missing data on 
all outcomes. The sample was 49.8% female and ranged between 40 to 65 years old (Mage = 
50.56, SDage = 5.90). Participants self-identified predominantly as Black/African-American 
(76.8%) and White (20.3%). Fifty-four percent of the sample had a high school diploma or 
GED and 26% had completed grammar school. According to the most recent definitions by 
the Department of Health and Human Services (2019), the poverty guideline in the U.S. for 
one person is $12,490 of household annual income; 77% of the study sample reported an 
household annual income of less than $10,000 and 16% reported having a household annual 
income of $20,000 or less.
The mean score for trait anxiety was 42.20 (SD = 11.31) out of a score of 80, which suggests 
that on average, the sample had high trait anxiety. The mean score for emotion dysregulation 
as measured by the DERS was 78.45 (SD = 25.62) out of 160, which represent scores 
comparable to previous studies comprised of samples with individuals in a substance use 
residential facility (e.g., Hopwood et al., 2015). The mean DUDIT score was 5.71 (SD = 
9.17) for drug use disorder symptoms out of a possible score of 44. Drug use disorder 
symptoms scores ranged from 0 to 38; 34.4% of the sample did not endorse DUDIT items. 
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According to the proposed DUDIT cut-off for problematic drug use, 38% of males and 
34.1% of females were above the threshold.
Participants indicated past year use of cannabis (23.3%), opiates (16.4%), and cocaine 
(19.5%). Seven percent of individuals who indicated using cannabis in the past year, 
reported using cannabis daily, and 38.6% reported using it between two and four times per 
month. A little less than half of the respondents who indicated that they had used opiates 
(47.2%) reported using the substance four or more times per week. Of the people who 
reported that they used cocaine in the past year, 28.6% indicated using the substance four or 
more times per week. Forty-three percent of the sample indicated having consumed alcohol 
in the past year; of those, 64.4% reported drinking alcohol once a week or more often, with 
half indicating that they consumed two to four drinks per sitting and 22% indicating that 
they consumed one drink per sitting. Furthermore, 17.5% of the sample reported using two 
or more illicit drugs in the past year.
Data Analytic Procedures—In order to examine the indirect effect of trait anxiety on 
drug use via emotion dysregulation, we examined a structural equation model (SEM) using 
Mplus 6.0 (Muthén & Muthén, 2010). Mplus utilizes maximum likelihood methods to 
produce parameter estimates that account for missing data. This approach yields less biased 
estimates in comparison to listwise and pairwise deletion when data is missing at random 
(Little & Rubin, 1987). We evaluated model fit using four indices, including: the χ2 statistic, 
the Comparative Fit Index (CFI; Bentler, 1990), the Tucker-Lewis Index (TLI; Tucker-Lewis 
Index, 1973) and the Root Mean Square Error of Approximation (RMSEA; Steiger, 1980).
Latent variables were used to create error-free estimates of our key constructs of interest. 
Because the DERS encompasses six previously established subscales (Gratz & Roemer, 
2004), we used each of these subscales as indicators of a latent emotion dysregulation. We 
utilized an item parceling approach to model self-reported trait anxiety and drug use by 
randomly selecting items to create three indicators of trait anxiety and drug use, respectively. 
This approach has been shown to reduce error variances and improve the reliability of 
estimated parameters compared to approaches that use single manifest measures (Kishton & 
Widaman, 1994; Little, Cunningham, Shahar & Widaman, 2002).
First, we examined a measurement model of our constructs to ensure appropriate model fit. 
Next, we examined a structural mediation model in which the latent trait anxiety factor 
predicted emotion dysregulation which, in turn, predicted drug use, controlling for 
participant gender, age, and race/ethnicity. The significance of the indirect effect was 
determined by estimating a 95% confidence interval band, using the bootstrapping procedure 
recommended by Preacher and Hayes (2008). As opposed to hypothesis testing which relies 
on assumptions regarding the normality of the distribution of the indirect effect (such as the 
Sobel test), bootstrapping procedures do not assume estimates of the indirect effect are 
normally distributed (Preacher & Hayes, 2008). A 95% confidence interval for the 
associated indirect effect that excludes 0 is statistically significant.
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Patterns of missing data were examined using Little’s Missing Completely at Random 
(MCAR) test (Little, 1988), which suggested that data could be considered MCAR: χ2 (20) 
= 29.76, p = .074. Bivariate correlations between all variables can be found in Table 1. Of 
note, adults who identified as non-Black reported higher levels of trait anxiety. Trait anxiety 
was also positively associated with greater drug use disorder symptoms and emotion 
dysregulation. Moreover, drug use was also correlated with emotion dysregulation.
Indirect Effects Model
First, we examined a measurement model of our multiply indicated latent constructs. The 
measurement model provided an acceptable fit to the data, indicating appropriate relations 
between latent variables and assigned indicators: χ2 (51) = 159.50, p < .001; CFI = .94; TLI 
= 0.92; and RMSEA = .09 [90% CI = .08 to .11]. Next, we examined our proposed 
mediation model (see Figure 1).
This model fit the data well: χ2 (81) = 190.56, p < .001; CFI = .94; TLI = 0.92; and RMSEA 
= .07 [90% CI = .06 to .09]. Findings suggested that identifying as Black was associated 
with greater emotion dysregulation while identifying as male was associated with greater 
drug use disorder symptoms. Results also indicated trait anxiety was positively related to 
emotion dysregulation but not drug use; whereas, emotion dysregulation was associated with 
drug use. Moreover, the indirect effect of trait anxiety on drug use via emotion dysregulation 
was significant: std. ind. eff. = .25, SE = .12, bootstrapped 95% CI = .03 to .481. In order to 
test the directionality of the hypothesized effects, we tested a model using a latent trait 
anxiety factor as the mediator and a latent emotion dysregulation factor as the predictor. The 
model continued to fit the data well: χ2 (81) = 185.38, p < .001; CFI = .94; TLI = 0.93; and 
RMSEA = .08 [90% CI = .06 to .09]. The pathway from emotion dysregulation to trait 
anxiety was significant (std. beta = 0.78, p < .001); however, the pathway from trait anxiety 
to a latent drug use problem factor was not significant (std. beta = −0.10, p = .523). 
Moreover, the indirect effect of emotion dysregulation on drug use disorder symptoms was 
not significant (std. est. = −0.08, SE = .120, 95% CI = −0.31 to 0.16).
Discussion
Consistent with our hypothesis, this study found that trait anxiety was indirectly associated 
to drug use disorder symptoms through emotion dysregulation in a sample of low-income 
adults above and beyond the effects of age, gender, and ethnicity/race. The results contribute 
in significant ways to the current literature. The empirical literature on the factors that 
underlie the anxiety–drug use association in low-income community samples is scarce and 
requires attention given reports that drug use is most pronounced among individuals with 
lower income and neighborhood disadvantage through increased social stressors and higher 
1A further model was examined that evaluated alcohol use disorder symptoms (as measured by the Alcohol Use Disorders 
Identification Test; World Health Organization, 1982) as an additional outcome. The model fit the data well: χ2 (90) = 204.15, p 
< .001; CFI = .94; TLI = 0.92; and RMSEA = .07 [90% CI = .06 to .09]. Findings suggest no significant direct effects of anxiety (std. 
beta = 0.15, p = .275) or emotion dysregulation (std. beta = 0.18, p = .177) on alcohol use disorder symptoms; moreover the indirect 
effect from anxiety to alcohol use disorder symptoms was not significant (std. est. = 0.15, SE = .11, 95% CI = −0.06 to 0.36).
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levels of psychological distress (e.g., Boardman et al., 2001; Johnson et al., 1999). 
Considered together, these results suggest an important pathway by which anxiety results in 
drug use and a potential target for future interventions. In fact, the study extends previous 
findings that unhealthy attempts to regulate emotions may lead to drug use problems among 
individuals with greater levels of trait anxiety. These results are consistent with existing 
literature that suggests that anxiety affects individuals’ ability to regulate their emotional 
experiences, driving increases in emotion dysregulation (Hofmann, Sawyer, Fang & 
Asnaani, 2012). Moreover, individuals with anxiety disorders display more marked 
difficulties regulating their emotions when induced to worry compared to those without 
anxiety (McLaughlin, Mennin & Farach, 2007). This may be particularly true in the context 
of chronic stress related to low socioeconomic status. In fact, the developmental literature 
suggests that adults who report greater numbers of adverse childhood experiences, also 
report higher levels of emotion dysregulation and anxiety symptoms (Poole, Dobson, & 
Pusch, 2017). It may be that these experiences shape stress reactivity patterns (e.g. 
McLaughlin et al., 2010) and as anxiety symptoms exacerbate experiences of everyday 
stress, these individuals become increasingly less able to regulate these stress responses. Our 
results also provide support for negative affect regulation models of drug use (e.g. Baker et 
al., 2004; Cooper, 1994; Cooper, Frone, Russell, & Mudar, 1995), and are consistent with 
coping models that posit that individuals engage in drug use to cope with experiences of 
distress (Khantzian, 1997).
Further, the results suggested that demographic characteristics such as race and gender were 
differentially related to the study variables. Identifying as Black was associated with higher 
emotion dysregulation scores assessed by the DERS. The DERS has been used with samples 
comprised of individuals predominantly identifying as Black (e.g., Hopwood et al., 2015; 
Weiss et al., 2012) and the present study’s mean scores are comparable to those of previous 
studies. Although the reason for higher mean DERS scores in this subsample are currently 
unknown, future research should assess invariance across race/ethnicity in this measure as 
well as examine the impact of race/ethnicity on these relations. Additionally, the study’s 
results indicated that being male was associated with higher drug use disorder symptoms, a 
finding that aligns with the extant literature that there exist gender differences underlying 
illicit drug use patterns (Becker & Hu, 2008), with substance use disorders being more 
prevalent in males (Merikangas & McClaire, 2012).
Findings suggest a number of important clinical and research implications. Although to our 
knowledge there are no cut-off scores for the trait STAI subscale and the DERS, the sample 
mean scores were elevated considering that participants were not treatment-seeking. For 
example, the sample’s DERS scores are comparable to the scores of individuals who were in 
an inpatient substance use treatment facility (Weiss et al., 2011; Hopwood et al., 2015). 
Furthermore, if we follow the cut-off guidelines for the STAI-trait subscale of a score of 40 
and above that has been suggested by some (e.g., Austin et al., 2005), on average the current 
sample had high trait anxiety. Moreover, more than a third of the sample endorsed 
problematic drug use disorder symptoms. Combined, the elevated scores in each of the 
variables assessed suggest that it is critical to provide accessible mental health care 
consisting of targeted interventions in community centers serving low-income individuals.
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Furthermore, these results support targeting emotion dysregulation as a mechanism to 
prevent or improve drug use outcomes among anxious individuals. Improving emotion 
dysregulation has been found to be a transdiagnostic predictor of treatment improvement 
across both anxiety and drug use disorders (Sloan et al., 2017), suggesting treatments 
targeting emotion dysregulation may critical to developing unified treatments for 
internalizing and externalizing behaviors. Fortunately, intervention research suggests that 
emotion dysregulation is a malleable construct, lending itself to specific intervention 
approaches, such as mindfulness and acceptance-based approaches (Gratz & Tull, 2010). 
Given these promising findings, it may also be that utilizing interventions that target emotion 
dysregulation adjunctive to more standard approaches for treating anxiety symptoms (such 
as cognitive behavioral therapy and exposure treatment) may prevent the onset of hazardous 
drug use in the longer term.
These findings should be considered within the context of study limitations. Foremost, these 
data were collected at a single time point, limiting our ability to examine longitudinal 
relations. Future prospective studies will be critical to establish mediation of emotion 
dysregulation in temporal relations between these constructs, which is necessary for 
determining causality (Maxwell & Cole, 2007). This concern may be mitigated in the 
current study in part by the alternative mediation model that was tested in which emotion 
dysregulation was specified as a predictor, and trait anxiety as the mediator. Second, all 
measures were self-report. This may have resulted in bias related to using a single, common 
method. Future studies should consider including more objective assessment methods, such 
as biological markers of recent drug use (Snell, Bhave, Takacs & Tabakoff, 2016). Finally, 
while the use of a low-income, traditionally underserved population is a unique strength of 
the current study, it is not possible to generalize these findings to samples engaged in either 
significant drug use or experiencing more impairing levels of anxiety symptoms. Thus, 
future research should examine these relations among clinical, treatment-seeking 
populations. The current study did not assess for homelessness; future research is necessary 
to examine the role of homelessness on the study variables of interest to understand whether 
these results are as robust in individuals who are low-income relative to those who are 
homeless. Despite these limitations, the study has various strengths including its focus on a 
historically underrepresented population in mental health research and the use of latent 
measures of study constructs.
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Standardized estimates for indirect effects model.
Note. Paths represented in bold are significant. STAI = State Trait Anxiety Inventory; DERS 
= Difficulties in Emotion Regulation Scale; DUDIT = Drug Use Disorders Identification 
Test. *p < .05, **p < .01
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